ZULIAN, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.398
AS - Asia 7.813
EU - Europa 3.323
AF - Africa 1.332
SA - Sud America 1.210
Continente sconosciuto - Info sul continente non disponibili 276
OC - Oceania 114
Totale 26.466
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.578
SG - Singapore 2.417
CN - Cina 1.262
VN - Vietnam 867
HK - Hong Kong 832
IT - Italia 792
BR - Brasile 681
BD - Bangladesh 488
DE - Germania 313
FR - Francia 255
FI - Finlandia 253
IN - India 240
PL - Polonia 230
JP - Giappone 149
CA - Canada 147
RU - Federazione Russa 140
IQ - Iraq 129
TR - Turchia 110
AR - Argentina 108
GB - Regno Unito 106
PH - Filippine 93
UA - Ucraina 88
NL - Olanda 87
SE - Svezia 84
MX - Messico 80
SA - Arabia Saudita 80
PK - Pakistan 79
ZA - Sudafrica 78
ID - Indonesia 72
KR - Corea 71
EC - Ecuador 70
CO - Colombia 68
ES - Italia 62
CR - Costa Rica 61
VE - Venezuela 56
CL - Cile 55
JO - Giordania 55
IE - Irlanda 54
TH - Thailandia 54
AE - Emirati Arabi Uniti 53
AT - Austria 52
MY - Malesia 51
KE - Kenya 50
JM - Giamaica 47
DZ - Algeria 46
UZ - Uzbekistan 46
AZ - Azerbaigian 44
CI - Costa d'Avorio 44
PA - Panama 44
PE - Perù 44
NP - Nepal 43
UG - Uganda 42
CZ - Repubblica Ceca 41
EG - Egitto 41
HU - Ungheria 41
RE - Reunion 41
BF - Burkina Faso 40
MG - Madagascar 40
PY - Paraguay 40
CY - Cipro 39
ET - Etiopia 39
KG - Kirghizistan 39
AL - Albania 38
LA - Repubblica Popolare Democratica del Laos 38
PS - Palestinian Territory 38
AM - Armenia 37
AO - Angola 37
BY - Bielorussia 37
MA - Marocco 37
NI - Nicaragua 37
PT - Portogallo 37
RS - Serbia 37
TN - Tunisia 37
BG - Bulgaria 36
GN - Guinea 35
HN - Honduras 35
LY - Libia 35
BB - Barbados 34
GR - Grecia 34
HR - Croazia 34
IR - Iran 34
NE - Niger 34
BE - Belgio 33
BO - Bolivia 33
CH - Svizzera 33
DK - Danimarca 33
GT - Guatemala 33
IL - Israele 33
LB - Libano 33
ML - Mali 33
SI - Slovenia 33
YT - Mayotte 33
CV - Capo Verde 32
GH - Ghana 32
MN - Mongolia 32
TW - Taiwan 32
LC - Santa Lucia 31
RO - Romania 31
SK - Slovacchia (Repubblica Slovacca) 31
SO - Somalia 31
Totale 24.754
Salva come PNG Salva come JPEG
Città #
Singapore 1.552
Ashburn 1.477
San Jose 1.408
Fairfield 1.287
Hong Kong 740
Woodbridge 599
Houston 575
Seattle 442
Cambridge 438
Wilmington 399
Council Bluffs 335
Santa Clara 305
Chandler 284
Ann Arbor 282
Beijing 256
Ho Chi Minh City 247
Los Angeles 216
Hanoi 197
Boardman 175
Helsinki 175
Bytom 169
Jacksonville 168
Princeton 160
Munich 156
New York 145
San Diego 145
Lauterbourg 144
Medford 124
Tokyo 109
Des Moines 92
Rome 82
Chicago 80
Milan 76
Dong Ket 66
São Paulo 62
Buffalo 54
Amman 53
San José 50
Roxbury 49
Dallas 48
Nanjing 46
Montreal 45
Dublin 44
Guangzhou 43
Hefei 43
Nairobi 43
Panama City 43
Naples 42
Orem 42
Abidjan 41
Baku 40
Kampala 40
Baghdad 39
Padova 39
Tashkent 39
Vienna 39
Managua 37
Haiphong 36
London 36
Warsaw 36
Antananarivo 35
Johannesburg 35
Conakry 34
Istanbul 34
Seoul 34
Ouagadougou 33
Bridgetown 32
Ulan Bator 32
Vientiane 32
Da Nang 31
Luanda 31
Lusaka 31
Addis Ababa 30
Bamako 30
Bishkek 30
Castries 30
Dakar 30
Dushanbe 30
Kingston 29
Kuala Lumpur 29
Yerevan 29
Accra 28
Montevideo 28
Riyadh 28
Salt Lake City 28
Andorra la Vella 27
Guayaquil 27
Harare 27
Niamey 27
Nuremberg 27
Praia 27
Frankfurt am Main 26
Jeddah 26
Phoenix 26
Podgorica 26
Brooklyn 25
Florence 25
Jinan 25
Nassau 25
Nouakchott 25
Totale 15.398
Salva come PNG Salva come JPEG
Nome #
Relapses of juvenile idiopathic arthritis in adulthood: A monocentric experience 417
Sarcopenia in juvenile localized scleroderma: new insights on deep involvement 354
Case report: Exploring under the tip of the iceberg: A case series of "self-limiting" multisystem inflammatory syndrome in children 348
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 324
CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis 310
A new computerized method for the assessment of skin lesions in Localized Scleroderma 292
Consensus-based recommendations for the management of juvenile localised scleroderma 273
Synovial hemangioma of infrapatellar (Hoffa) fat pad: Magnetic resonance imaging and ultrasound features 250
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial 237
Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis 234
Bone marrow edema in children: chronic nonbacterial osteomyelitis and its mimickers 233
Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy. 230
Severe clinical course of systemic lupus erythematosus in the first year of life 229
Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. 228
Consensus-based recommendations for the management of juvenile systemic sclerosis 224
Musculoskeletal pain in schoolchildren across puberty: A 3-year follow-up study 223
Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. 222
Monoarticular juvenile chronic arthritis of the shoulder: Report of a case and review of the literature 220
Anti-DFS70 antibodies in healthy schoolchildren: A follow-up analysis 216
Life-threatening systemic capillary leak syndrome in juvenile dermatomyositis 209
Early predictors at severe course of uveitis in oligoarticular Juvenile idiopathic arthritis 207
THU0532 RITUXIMAB FOR RAPIDLY PROGRESSIVE JUVENILE SYSTEMIC SCLEROSIS 207
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients 206
Abatacept for severe anti-tumor necrosis factor α refractory juvenile idiopathic arthritis-related uveitis 203
Case Report: Life-Threatening Macrophage Activation Syndrome With Fulminant Myocarditis Successfully Rescued by High Dose Intravenous Anakinra 203
Comparable efficacy of abatacept used as first-line or second-line biological agent for severe juvenile idiopathic arthritis-related uveitis 202
Long-term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients 199
Joint hypermobility, growing pain and obesity are mutually exclusive as causes of musculoskeletal pain in schoolchildren 198
Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma 198
Bone involvement as presenting sign of pediatric-onset Gaucher disease 196
Osteoperiostitis in children: proposal for a diagnostic algorithm 196
New Insights on Juvenile Psoriatic Arthritis 195
Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis 195
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: A randomised trial 192
Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis 190
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study 189
A computerized method to assess the skin involvement in localized scleroderma. 189
Treatment in Juvenile Scleroderma 188
Update of EULAR recommendations for the treatment of systemic sclerosis 187
Juvenile diabetes and systemic sclerosis: just a coincidence? 186
Prevalence of antinuclear antibodies in schoolchildren during puberty and possible relationship with musculoskeletal pain: A longitudinal study 186
Clinical features and outcome of cogan syndrome 186
Evolution of echocardiographic and cardiac magnetic resonance imaging abnormalities during follow-up in patients with multisystem inflammatory syndrome in children 184
Is Intraarticular Corticosteroid Injection (IAC) an effective therapy for Temporomandibular Joint (TMJ) Involvement in JIA? 182
Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review 181
Periodic fevers with aphthous stomatitis, pharyngitis, and adenitis (PFAPA) 181
Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes 180
Congenital localized scleroderma 180
A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea) 179
A preliminary disease severity score for juvenile systemic sclerosis 179
Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma 175
A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children 174
Localized scleroderma of the face 173
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry 173
Joint hypermobility and oligoarticular juvenile idiopathic arthritis: What relationship? 172
Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial 170
Methotrexate: New uses for an old drug 170
Monoarticular juvenile idiopathic arthritis as a distinct clinical entity A proof-of-concept study 169
Scleroderma in children 169
Renal Involvement in Multisystem Inflammatory Syndrome in Children: Not Only Acute Kidney Injury 168
Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population 168
CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis. 167
Prognostic role of euthyroid sick syndrome in MIS-C: results from a single-center observational study 166
A child with dermatomyositis and a suspicious lymphadenopathy. 166
CXCL10/CXCR3 interaction mediate chemotaxis of T cell into the synovium of children with oligoarticular juvenile idiopathic arthritis. 162
Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro 162
Acquired strabismus in linear scleroderma of the face 161
Recent advances in the management of juvenile systemic sclerosis 160
Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review 160
Immunopathogenesis of pediatric localized scleroderma 160
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis 159
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases - a multicentre prospective study 158
Cone beam computed tomography for the assessment of linear scleroderma of the face 158
Methotrexate Monotherapy in Juvenile Idiopathic Arthritis Associated Uveitis: Myth or Reality? 158
Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate 157
Systemic sclerosis in childhood: Clinical and immunologic features of 153 patients in an international database 155
Impact of guidelines implementation on empiric antibiotic treatment for pediatric uncomplicated osteomyelitis and septic arthritis over a ten-year period: Results of the ELECTRIC study (ostEomyeLitis and sEptiC arThritis tReatment in children) 154
Otolaryngological manifestations of rheumatic diseases in children. 154
Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra 154
Growth during tocilizumab therapy for polyarticular-course juvenile idiopathic arthritis: 2-year data from a phase III clinical trial 154
Localized scleroderma 153
Juvenile idiopathic arthritis: Current and future treatment options 153
The pediatric rheumatology European Society American College of Rheumatology European league against rheumatism provisional classification criteria for juvenile systemic sclerosis 152
Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis 152
Strategic use of levofolinic acid for methotrexate-induced side effects in juvenile idiopathic arthritis: a prospective observational study 151
Reflex sympathetic dystrophy in children 151
Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: Data from the Eustar database 151
Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: Pathogenetic and clinical implications 151
Immunopathogenesis of juvenile systemic sclerosis 151
Long non-coding RNA H19X as a regulator of mononuclear cell adhesion to the endothelium in systemic sclerosis 151
Responsiveness of outcome measures in juvenile chronic arthritis 149
Successful treatment of gangrene in systemic necrotizing vasculitis with iloprost 148
Systemic Sclerosis and Localized Scleroderma in Childhood 148
Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis 147
Is there a role for arthroscopic synovectomy in oligoarticular juvenile idiopathic arthritis? 147
Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis 146
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration 146
Early echocardiographic and cardiac mri findings in multisystem inflammatory syndrome in children 146
Non-invasive imaging and clinical skin scores in juvenile localised scleroderma 144
Infrared thermography in children: A reliable tool for differential diagnosis of peripheral microvascular dysfunction and Raynaud's phenomenon? 143
Totale 18.903
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.755
article - articoli 69.682
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 449
Totale 143.886
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.390 0 0 176 129 90 60 83 166 191 36 122 337
2022/2023800 231 44 22 50 122 110 9 52 96 14 41 9
2023/2024567 21 75 69 36 57 33 52 24 27 9 76 88
2024/20253.149 25 189 82 90 435 129 180 240 308 113 575 783
2025/202614.267 499 1.152 1.947 2.329 1.167 575 1.480 1.398 1.408 958 737 617
2026/20271.818 592 951 275 0 0 0 0 0 0 0 0 0
Totale 26.466